BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37777021)

  • 1. Cancer-associated fibroblasts secret extracellular vesicles to support cell proliferation and epithelial-mesenchymal transition in laryngeal squamous cell carcinoma.
    Li T; Tian L; Cao J; Liu M
    Mol Cell Probes; 2023 Dec; 72():101934. PubMed ID: 37777021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
    Song K; Yu P; Zhang C; Yuan Z; Zhang H
    Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.
    Shuang Y; Yao X; Liu J; Niu J; Guo W; Li C
    Hum Cell; 2022 Jul; 35(4):1084-1099. PubMed ID: 35545731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles and mechanisms of m
    Yan BR; Wang P; Li YS; Yang LK; Li QY; Kan X; Wang JT; Sun YN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1470-1478. PubMed ID: 36707952
    [No Abstract]   [Full Text] [Related]  

  • 7. m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways.
    Zhao K; Chen L; Xie Y; Ren N; Li J; Zhai X; Zheng S; Liu K; Wang C; Qiu Q; Peng X; Wang W; Liu J; Che Q; Fan J; Hu H; Liu M
    Cancer Lett; 2024 Apr; 587():216735. PubMed ID: 38369001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
    Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
    Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.
    Wan L; Gu D; Jin X
    Mol Biotechnol; 2022 Aug; 64(8):888-901. PubMed ID: 35218517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells.
    Li J; Momen-Heravi F; Wu X; He K
    Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
    Liu C; Lu Z; Liu H; Zhuang S; Guo P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA NORAD, soluble ICAM1 and their correlations may be related to the regulation of the tumor immune microenvironment in laryngeal squamous cell carcinoma (LSCC).
    Horozoglu C; Bal G; Kabadayı B; Hakan MT; Sönmez D; Nacarkahya G; Verim A; Yaylım İ
    Pathol Res Pract; 2023 Jun; 246():154494. PubMed ID: 37172522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells.
    Tan D; Li G; Zhang P; Peng C; He B
    Bioengineered; 2022 Jan; 13(1):1838-1857. PubMed ID: 35014944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
    Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
    Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis.
    Cui W; Meng W; Zhao L; Cao H; Chi W; Wang B
    Int J Oncol; 2019 Jun; 54(6):2005-2018. PubMed ID: 31081043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma.
    Ren P; Niu X; Zhao R; Liu J; Ren W; Dai H; Chen J; Yan J; Li B; Shao Y; Bai Y; Han P
    Cell Cycle; 2022 Apr; 21(7):697-707. PubMed ID: 35113007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CASC15 upregulates cyclin D1 by downregulating miR-365 in laryngeal squamous cell carcinoma to promote cell proliferation.
    Zhu M; Zhang C; Zhou P; Chen S; Zheng H
    J Otolaryngol Head Neck Surg; 2022 Feb; 51(1):8. PubMed ID: 35216636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA MIAT Regulates the Process of Laryngeal Squamous Cell Carcinoma Through Regulation of miR-147a/BCOR.
    Song D; Wu S; Hu H; Dai X; Wang X
    Arch Med Res; 2021 May; 52(4):371-379. PubMed ID: 33419582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
    Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.